Purification and identification of a second form of vitellogenin from ascites of medaka (Oryzias latipes) treated with estrogen.
Estrogen treatment of medaka leads to accumulation of ascites, in which vitellogenin (Vg) and choriogenins (precursors to vitelline envelope) are abundant. Besides those female-specific proteins, we detected a new component in ascites that cross-reacts with antiserum against egg yolk proteins. We tentatively named it egg yolk-related protein (YRP). YRP was purified from ascites by hydroxylapatite chromatography followed by gel filtration. Purified YRP had a molecular mass of 460 kDa in intact state while 570 kDa for Vg. The molecular weight of purified YRP on SDS-PAGE under both reducing and nonreducing conditions was 130 kDa. YRP was confirmed to be a lipoglycophosphoprotein by staining with Sudan black, periodic acid-Schiff (PAS) and methyl green. Amino acid composition of YRP resembled that of Vg except for a relatively low content of serine. A specific antiserum against YRP was raised in a rabbit. Antiserum against YRP specifically immunostained its antigen but not Vg or choriogenins. YRP was detected as a female-specific protein in serum of breeding medaka. The antiserum also cross-reacted with a band at 29 kDa in egg extracts, which is not immunoreactive to antiserum against Vg. These data show that YRP is a precursor to some egg yolk proteins with differing antigenicity from Vg (Hamazaki et al. '87). We thus conclude that YRP is a second form of medaka Vg and rename YRP as Vg 2 while formerly reported Vg as Vg 1.
Shimizu
Munetaka
M
School of Aquatic and Fishery Sciences, Box 355020, University of Washington, Seattle, Washington 98195, USA.
Fujiwara
Yumi
Y
Fukada
Haruhisa
H
Hara
Akihiko
A
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D000918:Antibody Specificity; D001202:Ascitic Fluid / Q000737:chemistry*; D015153:Blotting, Western; D004527:Egg Proteins / Q000737:chemistry / Q000276:immunology; D004591:Electrophoresis, Polyacrylamide Gel; D004967:Estrogens / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005779:Immunodiffusion; D008297:Male; D008970:Molecular Weight; D009990:Oryzias / Q000502:physiology*; D014819:Vitellogenins / Q000031:analogs & derivatives* / Q000737:chemistry / Q000276:immunology / Q000302:isolation & purification*
D000596:Amino Acids; D004527:Egg Proteins; D004967:Estrogens; D014819:Vitellogenins